Anti-TNF-Alpha-Adalimumab Therapy Is Associated with Persistent Improvement of Endothelial Function without Progression of Carotid Intima-Media Wall Thickness in Patients with Rheumatoid Arthritis Refractory to Conventional Therapy

To determine whether treatment with the anti-TNF-alpha blocker adalimumab yields persistent improvement of endothelial function and prevents from morphological progression of subclinical atherosclerosis in patients with rheumatoid arthritis (RA) refractory to conventional therapy, a series of 34 con...

Cur síos iomlán

Sonraí bibleagrafaíochta

Príomhchruthaitheoirí:	Carlos Gonzalez-Juanatey, Tomas R. Vazquez-Rodriguez, Jose A. Miranda-Filloy, Ines Gomez-Acebo, Ana Testa, Carlos Garcia-Porrua, Amalia Sanchez-Andrade, Javier Llorca, Miguel A. González-Gay
Formáid:	Artigo
Teanga:	Inglês
Foilsithe / Cruthaithe:	Wiley 2012-01-01
Sraith:	Mediators of Inflammation
Rochtain ar líne:	http://dx.doi.org/10.1155/2012/674265
Clibeanna:	Cuir clib leis Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!